Lunyi Lao

Array ( [id] => 6340702 [patent_doc_number] => 20020034510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'NOVEL ATPASE INHIBITOR' [patent_app_type] => new [patent_app_number] => 09/273135 [patent_app_country] => US [patent_app_date] => 1999-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14879 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034510.pdf [firstpage_image] =>[orig_patent_app_number] => 09273135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6893828 [patent_doc_number] => 20010016194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-23 [patent_title] => 'COMPOUNDS THAT INHIBIT THE BINDING OF RAF-1 OR 14-3-3 PROTEINS TO THE BETA CHAIN OF IL-2 RECEPTOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME' [patent_app_type] => new [patent_app_number] => 09/194145 [patent_app_country] => US [patent_app_date] => 1999-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15480 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20010016194.pdf [firstpage_image] =>[orig_patent_app_number] => 09194145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4274015 [patent_doc_number] => 06245897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Monoclonal antibody recognizing cell surface antigen CD14' [patent_app_type] => 1 [patent_app_number] => 9/262313 [patent_app_country] => US [patent_app_date] => 1999-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 5416 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245897.pdf [firstpage_image] =>[orig_patent_app_number] => 262313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248465 [patent_doc_number] => 06207419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Thrombin inhibitory agents and methods of using same' [patent_app_type] => 1 [patent_app_number] => 9/257581 [patent_app_country] => US [patent_app_date] => 1999-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 13099 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207419.pdf [firstpage_image] =>[orig_patent_app_number] => 257581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4399799 [patent_doc_number] => 06270746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Assay for the identification of IgE antibody suppressors' [patent_app_type] => 1 [patent_app_number] => 9/251175 [patent_app_country] => US [patent_app_date] => 1999-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4330 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270746.pdf [firstpage_image] =>[orig_patent_app_number] => 251175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284342 [patent_doc_number] => 06210912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Method for examining chronic rejection reactions following organ transplantation and method for determining urine components' [patent_app_type] => 1 [patent_app_number] => 9/230398 [patent_app_country] => US [patent_app_date] => 1999-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4017 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210912.pdf [firstpage_image] =>[orig_patent_app_number] => 230398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4357762 [patent_doc_number] => 06168925 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'GPIIb/IIIa platelet receptors assay' [patent_app_type] => 1 [patent_app_number] => 9/147654 [patent_app_country] => US [patent_app_date] => 1999-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 3414 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/168/06168925.pdf [firstpage_image] =>[orig_patent_app_number] => 147654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640033 [patent_doc_number] => 06395882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Selectin ligands' [patent_app_type] => B1 [patent_app_number] => 09/243560 [patent_app_country] => US [patent_app_date] => 1999-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18552 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395882.pdf [firstpage_image] =>[orig_patent_app_number] => 09243560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1461598 [patent_doc_number] => 06350447 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/240639 [patent_app_country] => US [patent_app_date] => 1999-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 48 [patent_no_of_words] => 43874 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350447.pdf [firstpage_image] =>[orig_patent_app_number] => 09240639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527844 [patent_doc_number] => 06479245 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Monoclonal antibody which is specific for activated coagulation factor VII, and its use' [patent_app_type] => B1 [patent_app_number] => 09/234504 [patent_app_country] => US [patent_app_date] => 1999-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2033 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479245.pdf [firstpage_image] =>[orig_patent_app_number] => 09234504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4265269 [patent_doc_number] => 06245332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Modulation of systemic memory T cell trafficking' [patent_app_type] => 1 [patent_app_number] => 9/232878 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 20 [patent_no_of_words] => 12587 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245332.pdf [firstpage_image] =>[orig_patent_app_number] => 232878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095206 [patent_doc_number] => 20020051748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'STABILIZED WATER-IN-OIL-IN-WATER ANTIGEN DELIVERY SYSTEM' [patent_app_type] => new [patent_app_number] => 09/226525 [patent_app_country] => US [patent_app_date] => 1998-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4016 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20020051748.pdf [firstpage_image] =>[orig_patent_app_number] => 09226525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106082 [patent_doc_number] => 06057113 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Mouse integrin subunits' [patent_app_type] => 1 [patent_app_number] => 9/218242 [patent_app_country] => US [patent_app_date] => 1998-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 7512 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057113.pdf [firstpage_image] =>[orig_patent_app_number] => 218242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173429 [patent_doc_number] => 06140472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Use of chimeric vaccinia virus complement control proteins to inhibit complement' [patent_app_type] => 1 [patent_app_number] => 9/201075 [patent_app_country] => US [patent_app_date] => 1998-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 7802 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140472.pdf [firstpage_image] =>[orig_patent_app_number] => 201075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602959 [patent_doc_number] => 06433138 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/199865 [patent_app_country] => US [patent_app_date] => 1998-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22966 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/433/06433138.pdf [firstpage_image] =>[orig_patent_app_number] => 09199865 [rel_patent_id] =>[rel_patent_doc_number] =>)